Intradetrusor Injections of Botulinum Toxin Type A in Children With Spina Bifida: A Multicenter Study

In this series, despite the fact that IDBTX-A enabled clinical improvement in 66% patients, urodynamic outcomes were poor resulting in a low global success rate (30%).